Comparison of demographic and salient immunological data for Raynaud’s phenomenon positive and Raynaud’s phenomenon negative patients
| Raynaud+ (n=40) | Raynaud− (n=53) | p Value | |
|---|---|---|---|
| *ANA were determined by indirect immunofluorescence on HEp-2 cell line; †anti-dsDNA were determined by indirect immunofluorescence on Crithidia luciliae; ‡other immunosuppressive drugs were cyclosporin A, azathioprine, or methotrexate; §non-significant. | |||
| Number | 40 | 53 | |
| Age (years), mean (SD) | 38.5 (12.9) | 38.5 (10.1) | NS§ |
| Women, No (%) | 36 (90) | 45 (85) | NS |
| Age of disease onset (years), mean (SD) | 30.6 (11.4) | 28.3 (9.9) | NS |
| Disease duration (years), mean (SD) | 7.4 (5.6) | 10.2 (8.8) | NS |
| ANA+*, No (%) | 40 (100) | 53 (100) | NS |
| Anti-dsDNA+†, No (%) | 19 (48) | 23 (43) | NS |
| Corticosteroids, No (%) | 40 (100) | 53 (100) | NS |
| Other immunosuppressive drugs‡, No (%) | 12 (30) | 18 (34) | NS |